Director dealings: Hikma gets shot in the arm as chief tops up
20th Apr 2016 16:38
(ShareCast News) - Hikma Pharmaceuticals's chief Said Darwazah boosted his stake in the generic drugs firm on Wednesday to 5.49% through the acquisition of 30,000 shares at an individual price of 2,271p. The transaction was carried out by Vidacos Nominees on behalf of Darhold Limited, in which Darwa
Read moreDirector dealing: Hikma directors keep buying
12th Apr 2016 15:32
(ShareCast News) - Hikma Pharmaceuticals' newest board member has bought himself some skin in the game, following his chief executive's lead. US public affairs veteran John Castellani, who was appointed to the board in February, spent around £53,000 buying 2,500 shares at a price of 2,103p apiece.
Read moreHikma filing for generic of Glaxo's Advair Diskus accepted by US FDA
8th Apr 2016 08:20
(ShareCast News) - Hikma Pharmaceuticals said on Friday that its abbreviated new drug application for fluticasone propionate and salmeterol inhalation powder has been accepted for filing by the Food and Drug Administration in the US. The product is the generic version of GlaxoSmithKline's Advair Dis
Read moreLondon-listed pharmas rally as Pfizer-Allergan deal collapses
6th Apr 2016 10:20
(ShareCast News) - Shares in pharmaceuticals companies Shire, AstraZeneca and GlaxoSmithKline rallied on Wednesday as investors bet that the termination of Pfizer's agreement to buy Allergan might make the London-listed companies bid targets. US drug maker Pfizer said on Wednesday that its $160bn ag
Read moreDirector dealings: Hikma boss buys £600K worth of shares
5th Apr 2016 17:15
(ShareCast News) - The chairman and chief executive of Hikma Pharmaceuticals has purchased more than £600,000 worth of shares in the drugmaker. Said Darwazah bought 30,000 shares for 2,055.00p each, totalling £616,499.98 JP Morgan on Wednesday reiterated its 'overweight' rating on the stock and set
Read moreHikma subsidiary receives FDA approval for Temozolomide capsules
29th Mar 2016 12:29
(ShareCast News) - Hikma Pharmaceuticals' fully-owned subsidiary West-Ward Pharmaceuticals has received approval from the US Food and Drug Administration for its abbreviated new drug application for Temozolomide capsules. Temozolomide is a chemotherapy agent used to treat a severe form of brain canc
Read moreWednesday broker round-up
16th Mar 2016 15:55
(ShareCast News) - Hikma Pharmaceuticals: Panmure Gordon upgrades to buy with a target price of 2120p. Greggs: Berenberg upgrades to hold, 1020p target. Firestone Diamonds: Panmure Gordon reiterates buy with a target price of 27p and Finncap stays at buy with a target price of 51p. Cairn Energy: C
Read moreLondon pre-open: Stocks seen a little higher ahead of Budget, FOMC
16th Mar 2016 07:33
(ShareCast News) - London stocks are set to open a little higher on Wednesday as the focus shifts to Chancellor George Osborne's Budget and the rate decision from the Federal Reserve. The FTSE 100 is seen starting 22 points firmer than Tuesday's close at 6,162. The Budget statement is at 1230 GM
Read moreCurrency headwinds push Hikma Pharmaceuticals profits down
16th Mar 2016 07:13
(ShareCast News) - Drug group Hikma Pharmaceuticals reported revenue of $1.44bn (£1.02bn) in its final results for 2015 on Wednesday, down 3% on what was an exceptionally strong 2014. Its gross margin remained in line with 2014, at 56.8%, reflecting Hikma's cost control efforts across the business.
Read moreMorrisons set for FTSE 100 return, Sports Direct in line for demotion
1st Mar 2016 15:19
(ShareCast News) - Morrisons, which announced a new grocery supply deal with Amazon.com on Monday, may work its way back into the FTSE 100 this month. The supermarket retailer, which was booted out at the last quarterly review, could be joined by newly-merged Paddy Power Betfair and private hospital
Read moreHikma hires well-connected American
22nd Feb 2016 12:00
(ShareCast News) - Hikma Pharmaceuticals has appointed US public affairs veteran John Castellani to its board. The FTSE 100 pharmaceuticals company said the appointment, which is effective from March 1, will see him join the the audit, remuneration, and compliance, responsibility and ethics committe
Read moreFTSE 100 movers: Housebuilders lead market higher
10th Feb 2016 14:26
(ShareCast News) - The FTSE 100 was set to turn things around on Wednesday, with the blue chip market up 48.39 points (0.86%) to 5,680.58 by mid-afternoon. Housebuilders were on the rise, including Taylor Wimpey, Berkeley Group Holdings and Barratt Developments, after sector peer Bellway reported st
Read moreHikma cuts cash consideration for Roxane by £370m
10th Feb 2016 07:15
(ShareCast News) - Hikma Pharmaceutical's takeover of Roxane Laboratories took on a new shape on Wednesday, with the cash consideration being almost halved off the back of significantly lower revenue projections. The FTSE 100 company had published a prospectus on 22 January in relation to the acquis
Read moreFTSE 100 movers: BP leads market fallers on losses
2nd Feb 2016 14:13
(ShareCast News) - The FTSE 100 was back below 6,000 on Tuesday, dropping 151.22 points (2.5%) to 5,908.88 by mid-afternoon. BP took the biggest hit after $2.6bn of write-downs and restructuring charges sent it crashing into losses for the fourth quarter and full year. A $3.31bn loss was reported f
Read moreTuesday newspaper share tips: Hikma Pharmaceuticals and Shire under the microscope
3rd Nov 2015 11:20
(ShareCast News) - Pharmaceuticals were on the newspaper pundits' agenda on Tuesday after Hikma Pharmaceuticals caused a bit of pain. The FTSE 100 company warned on Monday that its generics division is performing below expectations due to slower-than-expected growth in sales for its gout treatment M
Read more